Literature DB >> 26846952

Testosterone and Cardiovascular Disease.

Robert A Kloner1, Culley Carson2, Adrian Dobs3, Stephen Kopecky4, Emile R Mohler5.   

Abstract

Testosterone (T) is the principal male sex hormone. As men age, T levels typically fall. Symptoms of low T include decreased libido, vasomotor instability, and decreased bone mineral density. Other symptoms may include depression, fatigue, erectile dysfunction, and reduced muscle strength/mass. Epidemiology studies show that low levels of T are associated with more atherosclerosis, coronary artery disease, and cardiovascular events. However, treating hypogonadism in the aging male has resulted in discrepant results in regard to its effect on cardiovascular events. Emerging studies suggest that T may have a future role in treating heart failure, angina, and myocardial ischemia. A large, prospective, long-term study of T replacement, with a primary endpoint of a composite of adverse cardiovascular events including myocardial infarction, stroke, and/or cardiovascular death, is needed. The Food and Drug Administration recently put additional restrictions on T replacement therapy labeling and called for additional studies to determine its cardiac safety.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  angina; heart failure; hormone replacement therapy; major adverse cardiovascular events; male health; myocardial infarction

Mesh:

Substances:

Year:  2016        PMID: 26846952     DOI: 10.1016/j.jacc.2015.12.005

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  95 in total

Review 1.  Aging and sex hormones in males.

Authors:  Maria Chiara Decaroli; Vincenzo Rochira
Journal:  Virulence       Date:  2016-11-10       Impact factor: 5.882

2.  Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women.

Authors:  Richard V Clark; Ann C Walker; Susan Andrews; Philip Turnbull; Jeffrey A Wald; Mindy H Magee
Journal:  Br J Clin Pharmacol       Date:  2017-06-10       Impact factor: 4.335

Review 3.  Morbidity in Klinefelter syndrome and the effect of testosterone treatment.

Authors:  Simon Chang; Anne Skakkebaek; Shanlee M Davis; Claus H Gravholt
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-06-04       Impact factor: 3.908

Review 4.  Do nothing but observe microprolactinomas: when and how to replace sex hormones?

Authors:  Vivien Bonert
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

Review 5.  Role of Testosterone in the Treatment of Cardiovascular Disease.

Authors:  Carolyn M Webb; Peter Collins
Journal:  Eur Cardiol       Date:  2017-12

Review 6.  State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.

Authors:  Ahmed Elsherbiny; Matthew Tricomi; Digant Bhatt; Hari Kumar Dandapantula
Journal:  Curr Cardiol Rep       Date:  2017-04       Impact factor: 2.931

7.  Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.

Authors:  Matthew J Budoff; Susan S Ellenberg; Cora E Lewis; Emile R Mohler; Nanette K Wenger; Shalender Bhasin; Elizabeth Barrett-Connor; Ronald S Swerdloff; Alisa Stephens-Shields; Jane A Cauley; Jill P Crandall; Glenn R Cunningham; Kristine E Ensrud; Thomas M Gill; Alvin M Matsumoto; Mark E Molitch; Rine Nakanishi; Negin Nezarat; Suguru Matsumoto; Xiaoling Hou; Shehzad Basaria; Susan J Diem; Christina Wang; Denise Cifelli; Peter J Snyder
Journal:  JAMA       Date:  2017-02-21       Impact factor: 56.272

8.  Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.

Authors:  Mohammad Abu Zaid; Wambui G Gathirua-Mwangi; Chunkit Fung; Patrick O Monahan; Omar El-Charif; Annalynn M Williams; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair J Beard; Ryan Cook; Sandra K Althouse; Shirin Ardeshir-Rouhani-Fard; Paul C Dinh; Howard D Sesso; Lawrence H Einhorn; Sophie D Fossa; Lois B Travis
Journal:  J Natl Compr Canc Netw       Date:  2018-03       Impact factor: 11.908

9.  Older Patient and Caregiver Perspectives on Medication Value and Deprescribing: A Qualitative Study.

Authors:  Aimee N Pickering; Megan E Hamm; Alicia Dawdani; Joseph T Hanlon; Carolyn T Thorpe; Walid F Gellad; Thomas R Radomski
Journal:  J Am Geriatr Soc       Date:  2020-02-17       Impact factor: 5.562

10.  Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trial.

Authors:  Armin Zittermann; Jana B Ernst; Sylvana Prokop; Uwe Fuchs; Jens Dreier; Joachim Kuhn; Cornelius Knabbe; Heiner K Berthold; Ioanna Gouni-Berthold; Jan F Gummert; Jochen Börgermann; Stefan Pilz
Journal:  Eur J Nutr       Date:  2018-03-15       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.